BiotechTube
Home/Zora Biosciences/Reini Hurme
RH

Reini Hurme

CEO, Co-founder

Zora Biosciences

Therapeutic Areas

Cardiovascular DiseaseType 2 DiabetesFatty Liver Disease

Zora Biosciences Pipeline

DrugIndicationPhase
CERT2Cardiovascular Risk AssessmentCommercial
dSCOREType 2 Diabetes Risk AssessmentCommercial
Fatty Liver Disease TestNon-alcoholic Fatty Liver Disease (NAFLD/NASH)Development